KIR3DS1 is presumed to be an NK cell activation receptor. The gene has many (>40) inhibitory alleles, known as KIR3DL1. Various KIR3DL1 subtypes have been shown to interact directly with HLA-I proteins with the Bw4 public epitope. Regardless of its similarity to KIR3DL1, and its established role in HIV disease, KIR3DS1 has only recently been shown to be expressed on NK cells and no ligand has been described. Toward an understanding of KIR3DS1 ligand binding we developed a reporter system for the engagement of KIR3DS1. We continue to dissect the biochemical basis of the apparent lack of KIR3DS1 binding to HLA-Bw4. KIR3DL1 binds to HLA-Bw4 but the highly related KIR3DS1 does not. Despite the lack of direct evidence for interaction, genetic association studies suggest that carriage of KIR3DS1 and Bw4 provides strong protection from the advancement of HIV disease. We have carried out targeted mutagenesis that defines a critical role for Glycine 138 of KIR3DL1 for maintaining HLA-Bw4 binding. In addition, we are collaborating with a group in the process of solving the crystal structure of KIR3DL1 and testing the role that individual residues play in the interactions between this receptor and HLA-Bw4. Lastly, we continue to dissect the biochemical basis of the apparent lack of KIR3DS1 binding to HLA-Bw4. KIR3DL1 binds to HLA-Bw4 but the highly related KIR3DS1 does not. Despite the lack of direct evidence for interaction, genetic association studies suggest that carriage of KIR3DS1 and Bw4 provides strong protection from the advancement of HIV disease. We have carried out targeted mutagenesis that defines a critical role for Glycine 138 of KIR3DL1 for maintaining HLA-Bw4 binding. In addition, we are collaborating with a group in the process of solving the crystal structure of KIR3DL1 and testing the role that individual residues play in the interactions between this receptor and HLA-Bw4. Mutation of the residues implicated by the crystal structure has provided significant insight into the mechanisms of recognition and peptide specificity of KIR3DL1. By comparison, these data have provided important clues for our understanding of KIR3DS1. We have now begun to extend this analysis to KIR3DL2, a related receptor implicated in ankylosing spondylitis and cutaneous lymphoma.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Investigator-Initiated Intramural Research Projects (ZIA)
Project #
1ZIABC010747-08
Application #
8763199
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
8
Fiscal Year
2013
Total Cost
$205,508
Indirect Cost
Name
National Cancer Institute Division of Basic Sciences
Department
Type
DUNS #
City
State
Country
Zip Code
McCullen, M V; Li, H; Cam, M et al. (2016) Analysis of Ly49 gene transcripts in mature NK cells supports a role for the Pro1 element in gene activation, not gene expression. Genes Immun 17:349-57
Saunders, Philippa M; Pymm, Phillip; Pietra, Gabriella et al. (2016) Killer cell immunoglobulin-like receptor 3DL1 polymorphism defines distinct hierarchies of HLA class I recognition. J Exp Med 213:791-807
O'Connor, Geraldine M; Vivian, Julian P; Gostick, Emma et al. (2015) Peptide-Dependent Recognition of HLA-B*57:01 by KIR3DS1. J Virol 89:5213-21
Augusto, Danillo G; O'Connor, Geraldine M; Lobo-Alves, Sara C et al. (2015) Pemphigus is associated with KIR3DL2 expression levels and provides evidence that KIR3DL2 may bind HLA-A3 and A11 in vivo. Eur J Immunol 45:2052-60
Saunders, Philippa M; Vivian, Julian P; Baschuk, Nikola et al. (2015) The interaction of KIR3DL1*001 with HLA class I molecules is dependent upon molecular microarchitecture within the Bw4 epitope. J Immunol 194:781-9
O'Connor, Geraldine M; Vivian, Julian P; Widjaja, Jacqueline M et al. (2014) Mutational and structural analysis of KIR3DL1 reveals a lineage-defining allotypic dimorphism that impacts both HLA and peptide sensitivity. J Immunol 192:2875-84
O'Connor, Geraldine M; McVicar, Daniel (2013) The yin-yang of KIR3DL1/S1: molecular mechanisms and cellular function. Crit Rev Immunol 33:203-18
Vivian, Julian P; Duncan, Renee C; Berry, Richard et al. (2011) Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B. Nature 479:401-5
Fadda, Lena; O'Connor, Geraldine M; Kumar, Swati et al. (2011) Common HIV-1 peptide variants mediate differential binding of KIR3DL1 to HLA-Bw4 molecules. J Virol 85:5970-4
O'Connor, Geraldine M; Yamada, Eriko; Rampersaud, Andy et al. (2011) Analysis of binding of KIR3DS1*014 to HLA suggests distinct evolutionary history of KIR3DS1. J Immunol 187:2162-71

Showing the most recent 10 out of 11 publications